Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
about
Invasive breast cancer: stratification of histological grade by gene-based assays: a still relevant example from an older data setPrognostic value of gene signatures and proliferation in lymph-node-negative breast cancerChromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancerA signature inferred from Drosophila mitotic genes predicts survival of breast cancer patientsUtility of intraoperative frozen section in the diagnosis of periprosthetic joint infectionBiologic profiling of lymph node negative breast cancers by means of microRNA expression.Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapyMetronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsDietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metforminSecurin promotes the identification of favourable outcome in invasive breast cancer.Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosisLower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.Pathologic diagnosis, immunohistochemistry, multigene assays and breast cancer treatment: progress toward "precision" cancer therapy.Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures.Global mitotic phosphorylation of C2H2 zinc finger protein linker peptidesExpression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.Amelioration of the cyclophosphamide induced genotoxic damage in mice by the ethanolic extract of Equisetum arvenseA survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.The reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions.Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay).St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods.Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer.Vascular proliferation is a prognostic factor in breast cancer
P2860
Q28652779-02D95A27-3872-484A-929D-AA36FB12FF23Q31152670-CB354567-3BE5-4982-8871-97529E55FEFBQ33699104-40A5741E-744E-42E2-BE78-E4611F20F22DQ33840749-C894CF70-675D-4AE6-BC65-5C997ACD8233Q33905802-916F5936-CE6B-49B4-B105-645B612245FBQ34136195-8D0C1374-ACF6-45A5-BBDF-D7F9B9DEB393Q34537257-C88842C0-505C-4588-8019-7DCAD0C6ACA2Q37109324-467DB294-5673-4225-9615-C0F74B2EFB20Q37299288-91BEBA55-A3B8-419F-A345-4E7978BD3954Q37345354-0924CB8D-661F-4636-8030-990319AFDC5AQ37401531-6BE378CA-0D25-44FC-AAB7-0193BBA02BE5Q37692442-7C81772C-1AC8-439A-BB66-E3110CBD86C0Q38272730-B745EC19-E7D6-4FFF-8977-04584E4704DBQ39187437-C04D9210-EF9C-4C2F-8490-B062E17204C1Q39454138-E5E9F185-E5DA-4A1C-9981-F9E49FFDDC28Q39469438-F31D7370-0D27-49BD-BD09-2F76898BB837Q40362934-E576C75B-611C-4C3D-8D03-9D36C4074CF6Q41235139-6BF23912-AA52-4892-A8FE-0CF842B0A1A5Q41679054-B131B77A-8407-427A-AA05-8CE8E02F1307Q42438922-CCBD2A68-B9F9-4E71-A654-FA7AA564B08BQ43443180-43A99670-80D8-4632-871D-3158CE501BFFQ44477076-09A2C9BE-7353-419D-BF9F-4EF4EC6B232CQ46083625-E278AE48-D115-4ED6-BA6E-1A8412B704B1Q47289284-5ED9BA55-2DCC-4415-BD5E-3830DD2D5C23Q47869675-BDAEB9C7-E1C6-4116-A1A1-FD75E98EC75AQ48511251-D7EFE0E9-386F-4C8C-A11F-AA9D74EDCE1AQ50921836-6ACDA881-C017-47D9-8B14-9932DCE25F3CQ53119241-9BF241F2-54B1-4F02-9AFA-FAB85875406BQ53266957-92F899D8-D18D-4115-88C8-9ED3387A7C8EQ53663432-A61405F9-9E46-4C9F-AEC7-28EDA364CBAFQ59238285-69C44AD8-C992-4198-B290-2CEDA691A39F
P2860
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proliferation is the strongest ...... h molecular prognostic markers
@ast
Proliferation is the strongest ...... h molecular prognostic markers
@en
Proliferation is the strongest ...... h molecular prognostic markers
@nl
type
label
Proliferation is the strongest ...... h molecular prognostic markers
@ast
Proliferation is the strongest ...... h molecular prognostic markers
@en
Proliferation is the strongest ...... h molecular prognostic markers
@nl
prefLabel
Proliferation is the strongest ...... h molecular prognostic markers
@ast
Proliferation is the strongest ...... h molecular prognostic markers
@en
Proliferation is the strongest ...... h molecular prognostic markers
@nl
P2093
P2860
P50
P1476
Proliferation is the strongest ...... h molecular prognostic markers
@en
P2093
Axel Zur Hausen
Einar Gudlaugsson
Lydia Hui Ru Guo
Tone Hoel Lende
P2860
P2888
P304
P356
10.1007/S10549-008-0126-Y
P407
P577
2009-05-01T00:00:00Z
P5875
P6179
1038363744